Cargando…
Budget impact analysis of PCSK9 inhibitors costs from a community payers’ perspective in Apulia, Italy
INTRODUCTION: Despite established clinical efficacy of PCSK9 inhibitors (PCSK9i) in reducing cardiovascular events, their cost still represents a big matter of debate. We therefore sought to estimate possible impact of PCSK9i therapy from a community taxpayers’ perspective with a budget impact analy...
Autores principales: | Brunetti, Natale Daniele, De Gennaro, Luisa, Tricarico, Lucia, Caldarola, Pasquale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667935/ https://www.ncbi.nlm.nih.gov/pubmed/31413843 http://dx.doi.org/10.1136/openhrt-2019-001018 |
Ejemplares similares
-
2019 Italian Society of Cardiology Census on telemedicine in cardiovascular disease: a report from the working group on telecardiology and informatics
por: Brunetti, Natale Daniele, et al.
Publicado: (2020) -
Are valve clinics a sound investment for the health service? A cost-effectiveness model and an automated tool for cost estimation
por: Ionescu, Adrian, et al.
Publicado: (2015) -
The reduced cost of providing a nationally recognised service for familial hypercholesterolaemia
por: Pears, Robert, et al.
Publicado: (2014) -
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
por: McMurray, John J V, et al.
Publicado: (2018) -
Standardising practice in cardiology: reducing clinical variation and cost at Ochsner Health System
por: Oravetz, Phil, et al.
Publicado: (2019)